CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
about
CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progressionIdentifying and targeting tumor-initiating cells in the treatment of breast cancerCXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathwaysSimilar NF-κB gene signatures in TNF-α treated human endothelial cells and breast tumor biopsies.SCOUP: a probabilistic model based on the Ornstein-Uhlenbeck process to analyze single-cell expression data during differentiation.CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes.Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway.Clinical omics analysis of colorectal cancer incorporating copy number aberrations and gene expression data.Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approachesBone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins.Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteinsOverexpression of chemokine ligand 7 is associated with the progression of canine transmissible venereal tumor.Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers.Innate immunity pathways and breast cancer Risk in African American and European-American women in the Women's Circle of Health Study (WCHS).Interaction of aryl hydrocarbon receptor and NF-κB subunit RelB in breast cancer is associated with interleukin-8 overexpression.Association of high expression of Groβ with clinical and pathological characteristics of unfavorable prognosis in gastrointestinal stromal tumors.The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling.Bioengineering embryonic stem cell microenvironments for the study of breast cancerAberrantly expressed mRNAs and long non-coding RNAs in patients with invasive ductal breast carcinoma: a pilot study.A clinically relevant gene signature in triple negative and basal-like breast cancerHigh incidence of triple negative breast cancers following pregnancy and an associated gene expression signature.Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern.Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression.Acute impact of intermittent pneumatic leg compression frequency on limb hemodynamics, vascular function, and skeletal muscle gene expression in humans.Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude miceA CXCL1 paracrine network links cancer chemoresistance and metastasisIL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production.Polymorphisms in inflammation pathway genes and endometrial cancer riskChemokines: novel targets for breast cancer metastasisDifferential response of bovine mammary epithelial cells to Staphylococcus aureus or Escherichia coli agonists of the innate immune system.CXCL3 contributes to CD133(+) CSCs maintenance and forms a positive feedback regulation loop with CD133 in HCC via Erk1/2 phosphorylation.Opticin, a small leucine-rich proteoglycan, is uniquely expressed and translocated to the nucleus of chronic lymphocytic leukemia cells.Cell density regulates cancer metastasis via the Hippo pathway.FGF18 as a prognostic and therapeutic biomarker in ovarian cancer.A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB familyCytokine properties of prokineticins.Gene expression profiles of human adipose tissue-derived mesenchymal stem cells are modified by cell culture density.Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells.
P2860
Q24635943-FE4C23EE-144B-4A74-87AA-39E678500CF1Q26851827-5ABBA189-9C28-46AD-ABC0-3DC540A1C925Q30572945-F6231D1E-9FB9-4634-86B1-B362C7EFE348Q31022986-335419F3-9EA1-468B-948A-578C80DBBDC0Q31106549-FDCE7FF2-25C7-4B3C-9CCA-7925E8772C30Q33562564-3F947B4B-E705-4498-9768-386BD6DFD03CQ33590672-5E2694F6-4E26-466E-8976-6704073AD176Q33656571-75128863-FB19-482A-85CF-41C55508C3E6Q34119025-3EEFBAB9-3A9A-4080-A6C5-1B4F8E1863B7Q34119028-2A264393-F43C-41D8-BB59-0853530134ABQ34130792-CDF63C8D-354E-4FF7-B85B-1F1E1B262827Q34460058-458CB1CB-D3A8-43E8-B1C0-D30804D83210Q34471041-427106B0-94B0-4AA0-8382-521DBF047C89Q34788410-2CDF289A-8D26-47FD-A150-A2ECFF6D808EQ34977106-ACAB4C4A-A70D-40AF-8706-B5B44F54F0B7Q35102469-9D1AE2D4-6C1F-44ED-AC82-DD60FCA42C4FQ35511907-4B939552-FAB3-4A26-8D1E-2C9484E67AB3Q35572396-CC2CE8A4-A242-4DA2-875C-3C2D221CE390Q35577502-F07C6831-0A4B-4248-951A-F4EE9DD15116Q35600151-537863DC-AD18-43B0-9B63-6FCF6E520CF6Q35632602-D3E60C80-B7DA-4B31-80D1-27EE4726ADA3Q35683578-C902B4C8-673E-4F40-BF2E-EE6644D8BAA4Q35855332-AA6EE271-58C1-4B92-8AEC-A992080552D4Q35884951-82127F5A-95AA-40C6-BFEC-93FF0E66EF0CQ36026081-99011E28-5E34-4371-A184-BD08E55748F4Q36043058-88B65AB0-E1FC-4723-A084-46A69D4CBC0EQ36289925-8FF1A099-A9CE-4F7F-8805-7D81623A2503Q36482032-392ADE4D-DEE8-49BE-B852-48DC99E4D3D8Q36557205-38AFCF6B-3915-401C-8B0D-F5F22813BD51Q36915870-FCDC62B3-382A-440E-ABC5-7F463CFC37B8Q36918688-48B4C695-079A-479B-A5B0-EE07FC0326E6Q36940505-24119439-8633-41CB-9479-880530F0E550Q36964853-29EFE869-CE6A-4CC7-B1C6-9DF9F4F91815Q37153652-0426747A-D674-4296-A8F2-9EF19810137BQ37158424-8A736B60-73E8-4F8D-9F3F-2DDD3DE6F12AQ37200903-3E41F0EE-3FE5-40CE-BE68-6259170857CEQ37207403-BB0D93FE-69FC-4A62-B765-0700424BE3F0Q37223928-8C111840-3C15-470B-832A-5A327BBCC8FEQ37439151-D10AC4BE-C495-4BBE-87B8-61C599E68E6FQ37690257-78A82BCD-6CAB-4B64-BA2C-39DA2D3E37CF
P2860
CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
@en
CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
@nl
type
label
CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
@en
CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
@nl
prefLabel
CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
@en
CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
@nl
P2093
P356
P1476
CXC chemokines located in the 4q21 region are up-regulated in breast cancer
@en
P2093
Carine Chavey
Catherine Andrieu
Gwendal Lazennec
Jean-Marc Guinebretière
Ludovic Le Corre
Muriel Busson
Rosette Lidereau
Sandrine Burlinchon
P304
P356
10.1677/ERC.1.01301
P577
2007-12-01T00:00:00Z